|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600116539 |
|
最近更新日期: Date of Last Refreshed on: |
2026-01-12 14:44:22 |
|
注册时间: Date of Registration: |
2026-01-12 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
基于Learns模式的口腔健康宣教方案在头颈癌患者中的应用研究 |
|
Public title: |
The application of Oral Health Education Program in patients with head and neck cancer Based on Learns Model: A Randomized Controlled Trial. |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
肿瘤放疗患者健康教育方案构建及实证研究 |
|
Scientific title: |
Construction and Empirical Research of Health Education Programs for Cancer Patients undergoing Radiotherapy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
佘祎玮 |
研究负责人: |
买轩 |
|
Applicant: |
Yiwei She |
Study leader: |
Xuan Mai |
|
申请注册联系人电话: Applicant telephone: |
+86 152 3985 5372 |
研究负责人电话: Study leader's telephone: |
+86 150 9330 4335 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
173418731@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
363369425@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河南省郑州市东明路127号 |
研究负责人通讯地址: |
河南省郑州市东明路127号 |
|
Applicant address: |
No. 127, Dongming Road, Zhengzhou City, Henan Province |
Study leader's address: |
No. 127, Dongming Road, Zhengzhou City, Henan Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
河南省肿瘤医院 |
||
|
Applicant's institution: |
The Af?liated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital |
||
|
研究负责人所在单位: |
河南省肿瘤医院 |
||
|
Affiliation of the Leader: |
The Af?liated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025-318-003 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
河南省肿瘤医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Henan Cancer Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-07-09 00:00:00 |
||
|
伦理委员会联系人: |
杨树军 |
||
|
Contact Name of the ethic committee: |
Shujun Yang |
||
|
伦理委员会联系地址: |
河南省郑州市东明路127号 |
||
|
Contact Address of the ethic committee: |
No. 127, Dongming Road, Zhengzhou City, Henan Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 371 6558 8251 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
河南省肿瘤医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Af?liated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河南省郑州市东明路127号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 127, Dongming Road, Zhengzhou City, Henan Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self raised fund |
||||||||||||||||||||||
|
Target disease: |
Head and Neck cancer |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究以肿瘤放疗患者口腔健康问题为切入点,通过调查肿瘤放疗患者患者口腔健康素养现状,基于LEARNS模式构建肿瘤放疗患者口腔健康教育方案,并验证该干预方案在肿瘤放疗患者中的应用效果,为临床采用合理的口腔干预措施,减少肿瘤放疗患者痛苦,提高护理质量提供依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study takes the oral health problems of cancer patients undergoing radiotherapy as the entry point, investigates the status of oral health literacy of cancer patients undergoing radiotherapy, constructs an oral health education program for cancer patients undergoing radiotherapy based on LEARNS model, and verifies the application effect of the intervention program in cancer patients undergoing radiotherapy, so as to provide reasonable oral intervention measures for clinical use and reduce the suffering of cancer patients undergoing radiotherapy, to provide basis for improving nursing quality. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1. 经临床综合检查与组织病理学专科检查为恶性肿瘤的患者且治疗方式包括放疗; 2. 病情稳定、意识清楚、能正常沟通交流; 3. 年龄在 18 岁以上70岁以下; 4. 无口腔外伤、口腔癌症等; 5. Barthel 指数>=60 分(此范围患者生活自理能力处于轻度依赖以下,生活基本自理); 6. HeLD-14 得分<=46分(此范围口腔健康素养处于中等偏低水平); 7. 患者能够独立使用微信等手机软件; 8. 知情同意,自愿参加。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients with malignant tumors diagnosed by comprehensive clinical examination and histopathological examination and treated with radiotherapy; 2. stable condition, clear consciousness, normal communication; 3. Age above 18 years old and below 70 years old ; 4. no oral trauma, oral cancer, etc. 5. Barthel index >=60 points (patients in this range of self-care ability is under mild dependence, basic self-care); 6. HOLD-14 score <=46 points (this range of oral health literacy was at a low to medium level); 7. Patients could use wechat and other mobile apps independently. 8. Informed consent and voluntary participation. |
||||||||||||||||||||||
|
排除标准: |
1. 存在其他严重疾病者; 2. 伴有认知功能障碍及精神障碍者; 3. 正在参加其他研究的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. With other serious diseases; 2. With cognitive dysfunction and mental disorders; 3. Patients who are participating in other studies. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-06-25 00:00:00至 To 2026-06-26 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-10-20 00:00:00 至 To 2026-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
根据SPSS预设的随机种子和算法,由统计软件直接生成每个编号对应的组别。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Based on the preset random seed and algorithm of SPSS, the software directly generates the corresponding group for each number. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
对患者本人、干预者、评估者设盲 |
|
Blinding: |
Blinding of the patient, interventionist, and assessor |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
使用ResMan共享数据,预计共享时间:2027年12月。网址:http://www.medresman.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan, expected sharing time: December 2027 (http://www.medresman.org.cn) |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用纸质问卷。主要在研究现场采集,随访数据则通过电话回访补充记录在问卷上。所有数据最终录入密码保护的Excel文件,并进行加密备份。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A paper questionnaire was used. Data were collected at the study site, and follow-up data were collected through telephone interviews. All data were finally entered into a password-protected Excel file with an encrypted backup. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |